Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Kristina Brooks

Concepts (289)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anti-HIV Agents
30
2026
914
6.050
Why?
HIV Infections
36
2026
3215
4.620
Why?
Adenine
13
2026
339
3.130
Why?
Pregnancy Complications, Infectious
12
2026
438
2.820
Why?
Tenofovir
16
2026
300
2.770
Why?
Alanine
12
2026
171
2.600
Why?
Antiviral Agents
9
2026
779
2.240
Why?
Emtricitabine
12
2026
209
1.870
Why?
Adenosine Monophosphate
3
2026
87
1.750
Why?
Isoniazid
3
2026
71
1.640
Why?
Pre-Exposure Prophylaxis
8
2026
272
1.620
Why?
Tandem Mass Spectrometry
6
2026
576
1.570
Why?
Dried Blood Spot Testing
6
2026
129
1.540
Why?
Polyphosphates
5
2026
46
1.360
Why?
Sofosbuvir
5
2026
63
1.350
Why?
Leukocytes, Mononuclear
6
2026
585
1.240
Why?
Antitubercular Agents
3
2026
212
1.210
Why?
Heterocyclic Compounds, 3-Ring
6
2026
44
1.190
Why?
Phosphorous Acids
2
2019
15
1.180
Why?
Organophosphates
7
2026
179
1.170
Why?
Heterocyclic Compounds, 4 or More Rings
4
2026
25
0.900
Why?
Rifampin
4
2026
80
0.830
Why?
Darunavir
1
2023
20
0.800
Why?
Benzimidazoles
4
2026
191
0.790
Why?
Pharmacology, Clinical
1
2023
9
0.780
Why?
Hepatitis C
2
2026
251
0.780
Why?
Pregnancy
20
2026
7230
0.760
Why?
Fluorenes
2
2020
46
0.740
Why?
Medication Adherence
7
2026
535
0.740
Why?
Postpartum Period
9
2026
377
0.740
Why?
Drug Monitoring
4
2024
399
0.730
Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
2
2018
19
0.690
Why?
Blood Platelets
1
2025
382
0.680
Why?
Dideoxynucleosides
3
2026
27
0.660
Why?
Cobicistat
4
2023
5
0.630
Why?
Drug Administration Schedule
3
2018
790
0.620
Why?
Chromatography, Liquid
5
2026
453
0.600
Why?
Neutrophils
1
2025
1133
0.580
Why?
Biomarkers, Pharmacological
1
2018
26
0.560
Why?
Drug Interactions
6
2019
405
0.550
Why?
Antibiotics, Antitubercular
1
2018
35
0.550
Why?
Humans
62
2026
146342
0.550
Why?
HIV Integrase Inhibitors
1
2019
80
0.530
Why?
Busulfan
1
2017
15
0.530
Why?
Hepatitis C, Chronic
3
2026
150
0.530
Why?
Female
43
2026
79499
0.530
Why?
Transplantation Conditioning
1
2017
193
0.480
Why?
Adult
28
2026
41087
0.470
Why?
Nonprescription Drugs
1
2016
68
0.470
Why?
Desiccation
1
2015
26
0.450
Why?
Complementary Therapies
1
2016
93
0.450
Why?
Genotyping Techniques
1
2015
74
0.450
Why?
Carbamates
2
2026
52
0.450
Why?
Blood
1
2015
107
0.440
Why?
Tuberculosis, Multidrug-Resistant
2
2026
47
0.430
Why?
Infectious Disease Transmission, Vertical
4
2025
188
0.430
Why?
Models, Biological
5
2026
1761
0.410
Why?
Lamivudine
2
2025
63
0.410
Why?
Microbial Sensitivity Tests
1
2015
367
0.410
Why?
Specimen Handling
1
2015
178
0.400
Why?
Bronchitis
1
2013
28
0.380
Why?
Prospective Studies
9
2025
8123
0.380
Why?
Young Adult
17
2026
14330
0.380
Why?
Pyridones
5
2026
210
0.380
Why?
Rare Diseases
1
2013
117
0.360
Why?
Piperazines
5
2026
368
0.360
Why?
Cross-Over Studies
4
2023
615
0.350
Why?
Reproducibility of Results
3
2026
3416
0.350
Why?
Drug Combinations
5
2025
400
0.350
Why?
Hematopoietic Stem Cell Transplantation
1
2017
704
0.340
Why?
Cytokines
2
2018
2081
0.330
Why?
Protease Inhibitors
2
2022
103
0.330
Why?
HIV-1
2
2025
913
0.330
Why?
Oxazines
3
2025
36
0.320
Why?
Fontan Procedure
1
2013
200
0.320
Why?
Viral Load
4
2026
526
0.310
Why?
Male
24
2026
73396
0.290
Why?
Blood Chemical Analysis
2
2019
109
0.280
Why?
Transgender Persons
2
2022
213
0.280
Why?
Glycerophospholipids
2
2025
39
0.270
Why?
Benzamides
2
2026
226
0.270
Why?
Janus Kinase 1
2
2018
26
0.270
Why?
Janus Kinase 2
2
2018
31
0.270
Why?
Azetidines
2
2018
45
0.270
Why?
Janus Kinase Inhibitors
2
2018
27
0.260
Why?
Hepacivirus
3
2026
237
0.260
Why?
Dabigatran
2
2017
30
0.250
Why?
Healthy Volunteers
5
2018
218
0.250
Why?
Tablets
2
2025
41
0.250
Why?
Lactation
3
2023
193
0.240
Why?
Phthalimides
1
2026
3
0.240
Why?
Solid Phase Extraction
1
2026
28
0.240
Why?
Hydrazines
1
2026
37
0.240
Why?
Limit of Detection
1
2026
92
0.240
Why?
Clofazimine
1
2026
15
0.230
Why?
Injections
1
2026
201
0.230
Why?
Delayed-Action Preparations
1
2026
192
0.220
Why?
Pregnancy Trimester, Third
2
2025
117
0.220
Why?
Levofloxacin
1
2025
21
0.220
Why?
Administration, Oral
6
2026
872
0.220
Why?
Infant
7
2025
10114
0.220
Why?
Middle Aged
11
2026
36619
0.210
Why?
Chromatography, High Pressure Liquid
1
2026
588
0.210
Why?
Milk, Human
1
2026
176
0.200
Why?
Linear Models
1
2026
857
0.200
Why?
Sulfonamides
2
2018
594
0.200
Why?
Macaca nemestrina
1
2023
29
0.200
Why?
Prenatal Care
1
2024
310
0.180
Why?
Neonatal Sepsis
1
2022
9
0.180
Why?
Breast Feeding
2
2023
447
0.180
Why?
Practice Guidelines as Topic
2
2023
1591
0.170
Why?
Cell Phone
1
2022
83
0.170
Why?
HIV
1
2023
249
0.170
Why?
Adolescent
9
2022
22557
0.170
Why?
Osteoporotic Fractures
1
2022
62
0.170
Why?
Hip Fractures
1
2022
88
0.160
Why?
Ritonavir
2
2020
76
0.160
Why?
Pregnancy Outcome
2
2024
503
0.160
Why?
Oligonucleotides, Antisense
2
2017
122
0.160
Why?
Mobile Applications
1
2022
196
0.150
Why?
Antithrombins
2
2017
71
0.150
Why?
C-Reactive Protein
1
2022
429
0.150
Why?
Osteoporosis
1
2022
240
0.140
Why?
Fetus
1
2023
800
0.140
Why?
Alcohol Drinking
1
2025
850
0.140
Why?
Hereditary Autoinflammatory Diseases
1
2018
13
0.140
Why?
Ethanol
1
2023
630
0.140
Why?
COP9 Signalosome Complex
1
2017
5
0.130
Why?
Drug Dosage Calculations
1
2017
27
0.130
Why?
Macrophage Migration-Inhibitory Factors
1
2017
12
0.130
Why?
Treatment Outcome
6
2026
11821
0.130
Why?
Jejunostomy
1
2017
13
0.130
Why?
Hair Cells, Auditory, Inner
1
2017
17
0.130
Why?
Morpholinos
1
2017
30
0.130
Why?
Latent Tuberculosis
1
2018
71
0.130
Why?
Administration, Intravenous
1
2017
172
0.120
Why?
Interferons
1
2018
186
0.120
Why?
Cytochrome P-450 CYP3A Inhibitors
1
2016
18
0.120
Why?
Transplantation, Homologous
1
2017
416
0.120
Why?
Inflammation
2
2018
2919
0.120
Why?
Technetium Tc 99m Sulfur Colloid
1
2016
6
0.120
Why?
Benzopyrans
2
2026
31
0.110
Why?
Equipment and Supplies
1
2015
36
0.110
Why?
Cytochrome P-450 Enzyme System
1
2016
163
0.110
Why?
Randomized Controlled Trials as Topic
2
2020
1763
0.110
Why?
Neoplasms, Glandular and Epithelial
1
2016
52
0.110
Why?
Gadolinium
1
2016
78
0.110
Why?
Receptors, LDL
1
2015
53
0.110
Why?
Enteral Nutrition
1
2017
212
0.110
Why?
Radiopharmaceuticals
1
2016
210
0.110
Why?
Antibiotics, Antineoplastic
1
2016
141
0.110
Why?
Blood Coagulation
1
2016
267
0.110
Why?
Amides
2
2026
100
0.110
Why?
Drug Therapy, Combination
1
2017
1036
0.100
Why?
Child
7
2025
22693
0.100
Why?
Autoimmune Diseases
1
2017
467
0.100
Why?
Doxorubicin
1
2016
416
0.100
Why?
Tissue Plasminogen Activator
1
2015
245
0.100
Why?
Telemedicine
1
2022
966
0.100
Why?
Tumor Suppressor Proteins
1
2015
315
0.090
Why?
Predictive Value of Tests
1
2018
2113
0.090
Why?
Reverse Transcriptase Inhibitors
2
2022
89
0.090
Why?
Intestinal Mucosa
1
2017
666
0.090
Why?
Pyrimidines
2
2026
532
0.090
Why?
Benchmarking
2
2024
193
0.080
Why?
Blood Preservation
1
2015
346
0.080
Why?
Infant, Newborn
4
2025
6460
0.080
Why?
Influenza, Human
1
2017
640
0.080
Why?
Aged
4
2022
26432
0.080
Why?
Ovarian Neoplasms
1
2016
604
0.070
Why?
Health Knowledge, Attitudes, Practice
1
2018
1408
0.070
Why?
Contrast Media
3
2016
493
0.070
Why?
Compassionate Use Trials
2
2018
7
0.070
Why?
Biomarkers
3
2025
4340
0.070
Why?
Double-Blind Method
2
2026
2070
0.060
Why?
Thrombin Time
2
2017
13
0.060
Why?
Purines
2
2018
188
0.060
Why?
Furans
1
2026
26
0.060
Why?
Dideoxyadenosine
1
2025
4
0.060
Why?
Monte Carlo Method
1
2026
151
0.060
Why?
Drug Resistance, Viral
1
2026
127
0.060
Why?
Cyclopropanes
1
2025
83
0.050
Why?
Viremia
1
2026
158
0.050
Why?
Holistic Health
1
2024
12
0.050
Why?
South Africa
1
2026
262
0.050
Why?
Pyrazoles
2
2018
517
0.050
Why?
Brain
1
2016
2991
0.050
Why?
Animals
4
2023
38106
0.050
Why?
Cost-Benefit Analysis
3
2022
640
0.050
Why?
Case-Control Studies
2
2022
3647
0.050
Why?
Magnetic Resonance Imaging
1
2016
3926
0.050
Why?
Aged, 80 and over
1
2015
8391
0.050
Why?
Fetal Blood
1
2025
325
0.050
Why?
Anti-Retroviral Agents
1
2024
250
0.050
Why?
Child, Preschool
4
2025
11913
0.050
Why?
Ultrasonography
2
1996
788
0.040
Why?
Diphosphates
1
2021
20
0.040
Why?
Lung
1
2015
4122
0.040
Why?
Cohort Studies
2
2026
6077
0.040
Why?
Hormones
1
2022
134
0.040
Why?
Genome, Fungal
1
2002
48
0.040
Why?
United States
2
2016
16136
0.040
Why?
Schizosaccharomyces
1
2002
85
0.040
Why?
HTLV-I Infections
1
2000
29
0.040
Why?
Secondary Prevention
1
2022
248
0.040
Why?
Dermatitis
1
2000
20
0.040
Why?
Drug Approval
1
2020
94
0.040
Why?
Lopinavir
1
2020
30
0.040
Why?
Simethicone
2
1996
5
0.040
Why?
Cellulose
2
1996
55
0.040
Why?
Therapeutic Equivalency
1
2018
31
0.040
Why?
Estradiol
1
2022
517
0.030
Why?
Capsules
1
2018
40
0.030
Why?
Testosterone
1
2022
419
0.030
Why?
Developing Countries
1
2020
312
0.030
Why?
Nanomedicine
1
2018
47
0.030
Why?
Acoustic Maculae
1
2017
1
0.030
Why?
Oocysts
1
2017
7
0.030
Why?
Drug Compounding
1
2018
106
0.030
Why?
Viral Matrix Proteins
1
2017
28
0.030
Why?
Saccule and Utricle
1
2017
13
0.030
Why?
Placebos
1
2017
192
0.030
Why?
Proteinuria
1
2017
103
0.030
Why?
Chemokine CCL2
1
2017
112
0.030
Why?
Embryo, Nonmammalian
1
2017
171
0.030
Why?
Area Under Curve
1
2017
335
0.030
Why?
Influenza A virus
1
2017
120
0.030
Why?
Headache
1
2017
150
0.030
Why?
Infusions, Intravenous
1
2017
432
0.030
Why?
Tubulin
1
2017
124
0.030
Why?
Patient Selection
1
2020
728
0.030
Why?
Hand-Foot Syndrome
1
2016
2
0.030
Why?
Axons
1
2017
205
0.030
Why?
Low Density Lipoprotein Receptor-Related Protein-1
1
2015
12
0.030
Why?
Tomography, Emission-Computed, Single-Photon
1
2016
104
0.030
Why?
Carboplatin
1
2016
168
0.030
Why?
Clinical Trials as Topic
1
2020
1064
0.030
Why?
Injections, Spinal
1
2015
120
0.030
Why?
Actins
1
2017
422
0.030
Why?
National Institutes of Health (U.S.)
1
2016
147
0.030
Why?
Primary Cell Culture
1
2015
173
0.030
Why?
Logistic Models
1
2020
2126
0.030
Why?
Intestines
1
2017
351
0.030
Why?
Protein Biosynthesis
1
2017
449
0.030
Why?
Epithelium
1
2015
295
0.030
Why?
Endocytosis
1
2015
170
0.030
Why?
Pregnancy Complications
1
2020
609
0.030
Why?
Glomerular Filtration Rate
1
2017
745
0.030
Why?
Gastrointestinal Diseases
1
1996
220
0.020
Why?
In Vitro Techniques
1
2015
1041
0.020
Why?
Body Weight
1
2017
968
0.020
Why?
Quality Improvement
1
2022
1354
0.020
Why?
Zebrafish
1
2017
536
0.020
Why?
Bronchoalveolar Lavage Fluid
1
2015
642
0.020
Why?
Algorithms
1
2020
1849
0.020
Why?
Evidence-Based Medicine
1
2016
731
0.020
Why?
Decision Support Techniques
1
1996
478
0.020
Why?
Polyethylene Glycols
1
2016
650
0.020
Why?
Incidence
1
2017
2936
0.020
Why?
Age Factors
1
2017
3347
0.020
Why?
Genetic Predisposition to Disease
1
2017
2488
0.020
Why?
Phenotype
1
2016
3206
0.020
Why?
Liver
1
2015
1864
0.020
Why?
Tomography, X-Ray Computed
1
2016
2786
0.010
Why?
Mice, Inbred C57BL
1
2015
6034
0.010
Why?
Gene Duplication
1
2002
67
0.010
Why?
Chromosomes, Fungal
1
2002
43
0.010
Why?
Eukaryotic Cells
1
2002
39
0.010
Why?
DNA, Fungal
1
2002
76
0.010
Why?
Genetic Diseases, Inborn
1
2002
45
0.010
Why?
Centromere
1
2002
62
0.010
Why?
Fungal Proteins
1
2002
137
0.010
Why?
Retrospective Studies
1
2020
17438
0.010
Why?
Sensitivity and Specificity
2
1996
1998
0.010
Why?
Introns
1
2002
257
0.010
Why?
Chromosome Mapping
1
2002
508
0.010
Why?
CD4-CD8 Ratio
1
2000
23
0.010
Why?
Immunoglobulins
1
2000
162
0.010
Why?
Protein Structure, Tertiary
1
2002
834
0.010
Why?
Sequence Analysis, DNA
1
2002
771
0.010
Why?
HLA Antigens
1
2000
241
0.010
Why?
Base Sequence
1
2002
2123
0.010
Why?
Haplotypes
1
2000
506
0.010
Why?
T-Lymphocyte Subsets
1
2000
416
0.010
Why?
Mice
1
2015
18297
0.010
Why?
Artifacts
1
1996
143
0.010
Why?
Abdomen
1
1996
142
0.010
Why?
Dose-Response Relationship, Drug
1
1996
2022
0.010
Why?
Follow-Up Studies
1
2000
5439
0.000
Why?
Brooks's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)